首页 News 正文

AstraZeneca announced on June 26 that the National Medical Products Administration of China officially approved Teresa& on June 18, 2024; reg; The combination of pemetrexed and platinum based chemotherapy drugs is used as first-line treatment for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 (L858R) replacement mutation.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

白云追月素 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    39